✦ LIBER ✦

Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer

✍ Scribed by Chow, L W-C; Xu, B; Gupta, S; Freyman, A; Zhao, Y; Abbas, R; Vo Van, M-L; Bondarenko, I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted therapies: Combined lapatinib a

✍ Castañeda, Carlos A.; Gomez, Henry L. 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

Paclitaxel, carboplatin, and trastuzumab

✍ Andrew D. Seidman; Larry Norton 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 136 KB

Safety and efficacy of neratinib in comb

✍ Jankowitz, Rachel C.; Abraham, Jame; Tan, Antoinette R.; Limentani, Steven A.; T 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 238 KB

Antiangiogenic Therapy in Patients With

✍ Le Saux, Olivia; You, Benoît; Freyer, Gilles 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Trastuzumab in combination with metronom

✍ Laura Orlando; Anna Cardillo; Raffaella Ghisini; Andrea Rocca; Alessandra Balduz 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 252 KB

Maintenance bevacizumab beyond first-lin

✍ Alessandra Fabi, Michelangelo Russillo, Gianluigi Ferretti, Giulio Metro, Cecili 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 188 KB